US-based robotic surgery technology provider Activ Surgical has secured $45m in a series B round led by investment firm Cota Capital that also featured graphics processing unit producer Nvidia.
BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures and D. One Vision Management also took part, as did DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV) and Artis Ventures.
Activ has developed artificial intelligence-equipped hardware and software intended to facilitate autonomous robotic surgery.
The company’s first product, ActivSight, is an optical device that provides surgeons with real-time visual data, intelligence and imaging to improve decision making and reduce the risk of error. It has also created an augmented reality-based software suite called ActivInsights.
The funding will be used to increase the availability of ActivInsights as well as supporting the commercialisation of Activ’s products in the US and applications for regulatory accreditation in the European Union.
Activ has raised $87m of financing to date including $15m in a July 2020 round led by Artis Ventures and backed by DNS Capital, GPV, LRVHealth, Rising Tide VC and Tao Capital Partners.
Consumer electronics producer Sony’s Innovation Fund participated in an $11m series A round for Activ in October 2019 that was led by DNS Capital and which included GPV, Mintz, Rising Tide Financial, Tao Capital Partners and WS Investment Company.
The company also pulled in $12.9m from undisclosed investors in July 2019, according to a regulatory filing. Another filing shows it had received $2m of debt financing in 2018 after a $1.5m equity round the year before.